Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases

Table 2

Osteoporosis treatment for patients identified as high-risk for glucocorticoid-induced osteoporosis.

	Prescribed no. (%)
Osteoporosis treatment	56 (93)
Bisphosphonates	30 (50)
With active vitamin D3	15 (25)
Without active vitamin D3	15 (25)
Teriparatide	3 (5)
Denosumab with vitamin D3	12 (20)
Active vitamin D3 monotherapy	11 (18)
Alfacalcidol	7 (12)
Eldecalcitol	4 (6)
Untreated	4 (6)